Status | Study |
Completed |
Study Name: Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas Condition: Childhood Alveolar Soft-part Sarcoma Childhood Angiosarcoma Date: 2012-03-27 Interventions: Other: laboratory biomarker analysis Correlative studies |
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Adult Date: 2012-02-06 Interventions: Drug: Gemcitabine Hydrochloride |
Recruiting |
Study Name: NHS-IL12 for Solid Tumors Condition: Epithelial Neoplasms, Malignant Epithelial Tumors, Malignant Date: 2011-08-13 Interventions: Drug: NHS-IL-12 NHS-IL12 is an investigational agent supplied to investigators by the manufacturer EMD S |
Recruiting |
Study Name: Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma Condition: Sarcoma Date: 2011-04-27 Interventions: Procedure: therapeutic conventional surgery |
Terminated |
Study Name: Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Condition: Sarcoma Date: 2010-08-25 Interventions: Drug: doxorubicin hydrochloride Drug: trab |
Completed |
Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Adult Date: 2010-06-29 Interventions: Drug: Gamma-Secretase Inhibitor RO4929097 |
Terminated |
Study Name: Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX Condition: Sarcoma Date: 2009-05-09 Interventions: Genetic: microarray analysis Genetic: mole |
Terminated |
Study Name: Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Condition: Sarcoma Date: 2008-08-22 Interventions: Genetic: gene expression analysis Genetic: |
Completed |
Study Name: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Condition: Adult Angiosarcoma Adult Desmoplastic Small Round Cell Tumor Date: 2008-07-19 Interventions: Biological: Cixutumumab Given |
Completed |
Study Name: BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Condition: Breast Cancer Endometrial Cancer Head and Neck Cancer Date: 2007-09-05 Interventions: Drug: BI 2536 Other: high performance liqu |